Phyllis McKiernan, a nurse practitioner at John Theurer Cancer Center, Hackensack Medical Center, discusses a study of outcomes of autologous stem cell transplantation in very elderly patients with multiple myeloma.
Phyllis McKiernan, a nurse practitioner at John Theurer Cancer Center, Hackensack Medical Center, discusses a study of outcomes of autologous stem cell transplantation in very elderly patients with multiple myeloma.
This study looked at 496 patients who underwent autologous stem cell transplantation for multiple myeloma over a 10-year period. Of the 496 patients, 24 patients were over the age of 75.
McKiernan notes that elderly patients are typically considered to be those who are over the age of 65, however, many patients undergo transplantation at an even older age. Thus, investigators wanted to follow the patients who were over the age of 75 to determine what influenced the course of their transplantation and their outcomes.
Brain Cancer Awareness Month: Challenges and Innovations in Treatment
May 13th 2024In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of targeting brain tumors, emerging therapies, and strategies to overcome the blood-brain barrier.
Read More
How BCMA CAR T-Cell Therapy Provides Later-Line Options in R/R Multiple Myeloma
May 10th 2024During a Case-Based Roundtable® event, Abdullah Khan, MBBS, discussed the different outcomes with idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma in both the clinic and real-world settings in the second article of a 2-part series.
Read More